Veterinary Medicines

Vidalta 15 mg prolonged-release tablets for cats

Authorised
  • Carbimazole
Download as PDF

Product identification

Medicine name:
Vidalta 15 mg prolonged-release tablets for cats
Vidalta 15 mg Retardtabletten für Katzen
Active substance:
  • Carbimazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carbimazole
    15.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • High density polyethylene container of 100 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
  • High density polyethylene container of 30 closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
  • 6 high density polyethylene containers of 30 closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
  • 6 High density polyethylene containers of 100 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401599.01.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0442/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."